TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -13.81%3.88B | -1.91%7.12B | 4.15%4.51B | -29.63%7.26B | -27.71%4.33B | 9.95%10.32B | 27.43%5.98B | 13.59%9.39B | 9.28%4.7B | 18.08%8.26B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | 28.27%-46.52M | 30.18%-119.46M | 18.28%-64.86M | -32.80%-171.11M | -21.22%-79.36M | -32.75%-128.85M | -81.27%-65.47M | 44.90%-97.06M | 63.01%-36.12M | -56.04%-176.15M |
Dividend (income)- adjustment | ---- | ---857K | ---857K | ---- | ---- | 97.93%-165K | 92.63%-155K | -2,366.25%-7.97M | -1,062.43%-2.1M | 80.59%-323K |
Attributable subsidiary (profit) loss | 121.30%11.27M | 10.13%-135.96M | 43.68%-52.9M | 12.67%-151.28M | -37.41%-93.93M | 21.01%-173.21M | 38.75%-68.36M | 18.03%-219.28M | -16.94%-111.62M | -65.61%-267.51M |
Impairment and provisions: | -81.09%34.46M | -50.70%324.47M | -59.94%182.21M | --658.16M | 5,407.92%454.84M | ---- | --8.26M | ---- | ---- | ---- |
-Impairment of property, plant and equipment (reversal) | ---- | 2,348.06%380.09M | ---- | --15.53M | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairmen of inventory (reversal) | ---- | --35.41M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | -89.19%20.14M | ---- | --186.25M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of goodwill | ---- | ---- | ---- | --607.84M | --376.71M | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | 454.68%14.32M | -361.61%-91.02M | -105.17%-4.04M | --34.79M | 846.22%78.14M | ---- | --8.26M | ---- | ---- | ---- |
Revaluation surplus: | -130.26%-7.49M | 226.55%51.55M | 123.48%24.76M | -72.60%15.79M | -34.40%11.08M | 20.67%57.62M | 352.47%16.89M | 274.50%47.75M | -293.55%-6.69M | -698.19%-27.36M |
-Fair value of investment properties (increase) | ---- | ---1.38M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other fair value changes | -130.26%-7.49M | 235.31%52.93M | 123.48%24.76M | -72.60%15.79M | -34.40%11.08M | 20.67%57.62M | 352.47%16.89M | 274.50%47.75M | -293.55%-6.69M | -698.19%-27.36M |
Asset sale loss (gain): | -176.95%-237K | 116.31%2.88M | 275.61%308K | -120.09%-17.67M | 105.18%82K | -44.42%87.95M | -793.79%-1.58M | 6,679.43%158.23M | -122.84%-177K | -43.25%2.33M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | -1,069,600.00%-21.39M | ---- | -100.00%-2K | ---- | --158.2M | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | -176.95%-237K | -99.20%30K | 275.61%308K | -13.68%3.73M | 105.18%82K | 15,328.57%4.32M | -793.79%-1.58M | -98.80%28K | -122.84%-177K | -43.25%2.33M |
-Loss (gain) from selling other assets | ---- | --2.85M | ---- | ---- | ---- | --83.63M | ---- | ---- | ---- | ---- |
Depreciation and amortization: | -1.05%1.12B | 4.07%2.18B | 9.10%1.13B | 28.50%2.09B | 33.56%1.04B | 37.22%1.63B | 43.46%776.57M | 37.39%1.19B | 44.28%541.33M | 39.12%862.98M |
-Amortization of intangible assets | -2.57%739.88M | 5.13%1.44B | 12.06%759.41M | 30.87%1.37B | 36.93%677.69M | 41.73%1.05B | 47.73%494.92M | 46.72%740.59M | 58.95%335.02M | 48.04%504.78M |
Financial expense | -11.04%1.55B | 1.13%3.53B | 3.25%1.74B | 13.28%3.49B | 17.23%1.68B | 35.11%3.08B | 26.94%1.44B | 24.49%2.28B | 36.59%1.13B | 33.05%1.83B |
Exchange Loss (gain) | 100.30%1.73M | 29.53%-711.5M | -184.54%-570.79M | -829.86%-1.01B | -256.67%-200.6M | -108.89%-108.58M | 199.15%128.04M | 464.91%1.22B | 45.55%-129.15M | 9.64%-334.59M |
Special items | ---- | 36.53%869.34M | ---- | 21.18%636.76M | 58.14%234.65M | 26.43%525.45M | 168.65%148.38M | 692.96%415.62M | 182.34%55.23M | -7.16%52.41M |
Operating profit before the change of operating capital | -5.09%6.54B | 2.39%13.11B | -6.51%6.89B | -16.25%12.8B | -11.82%7.37B | 6.38%15.29B | 36.25%8.36B | 40.79%14.37B | 20.50%6.14B | 21.42%10.21B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | -45.53%-132.87M | -57.73%57.53M | -147.26%-91.3M | 187.51%136.1M | 154.71%193.19M | 13.41%-155.52M | 7.09%-353.13M | -7.42%-179.6M | 7.46%-380.07M | 1.71%-167.19M |
Accounts receivable (increase)decrease | 65.92%-942.17M | -142.65%-4.64B | -37.90%-2.76B | 66.87%-1.91B | 5.70%-2B | -23.50%-5.77B | -25.03%-2.13B | -35.76%-4.67B | 6.67%-1.7B | -46.95%-3.44B |
Accounts payable increase (decrease) | 52.73%-1.39B | -216.15%-4.46B | -85.49%-2.95B | -122.64%-1.41B | -147.55%-1.59B | 84.19%6.24B | 5,156.06%3.34B | -7.45%3.39B | -90.97%63.55M | 117.58%3.66B |
Special items for working capital changes | -8.54%-1.18B | 79.52%-1.1B | 75.89%-1.08B | 66.91%-5.36B | 61.14%-4.49B | 19.90%-16.2B | -25.93%-11.56B | -16.58%-20.22B | -33.74%-9.18B | -50.12%-17.35B |
Cash from business operations | 31,384.63%2.9B | -30.28%2.97B | 101.78%9.21M | 808.46%4.26B | 77.85%-516.83M | 91.79%-600.78M | 53.86%-2.33B | -3.21%-7.32B | -53.36%-5.06B | -78.14%-7.09B |
China income tax paid | -234.00%-789.48M | -41.56%-591.8M | 52.48%-236.37M | 61.67%-418.05M | 12.97%-497.46M | -13.07%-1.09B | -37.71%-571.6M | -68.35%-964.68M | -65.19%-415.08M | -15.02%-573.02M |
Interest received - operating | -28.27%46.52M | -30.18%119.46M | -18.28%64.86M | 32.80%171.11M | 21.22%79.36M | 32.75%128.85M | 81.27%65.47M | -44.90%97.06M | -63.01%36.12M | 56.04%176.15M |
Net cash from operations | 1,429.21%2.16B | -37.77%2.5B | 82.64%-162.31M | 356.57%4.01B | 67.07%-934.93M | 80.91%-1.56B | 47.76%-2.84B | -9.33%-8.19B | -57.52%-5.44B | -71.51%-7.49B |
Cash flow from investment activities | ||||||||||
Dividend received - investment | 2,673.40%23.77M | 102.68%28.52M | --857K | 8,427.27%14.07M | ---- | -97.93%165K | -92.63%155K | 2,366.25%7.97M | 1,062.43%2.1M | -80.59%323K |
Loan receivable (increase) decrease | 3.58%376K | 3.40%729K | -0.55%363K | -3.03%705K | 5.80%365K | 9.32%727K | 14.24%345K | 13.29%665K | 2.03%302K | 3.71%587K |
Decrease in deposits (increase) | 78.53%-1.4M | 117.21%4.08M | 88.49%-6.53M | -779.01%-23.68M | -271.16%-56.69M | -78.34%3.49M | -193.00%-15.28M | -99.39%16.11M | -99.39%16.43M | 237.38%2.64B |
Sale of fixed assets | 389.81%18.88M | 23.18%56.69M | -88.41%3.86M | 67.27%46.02M | 69.09%33.26M | 306.49%27.51M | 217.86%19.67M | 45.92%6.77M | 2,846.67%6.19M | -63.14%4.64M |
Purchase of fixed assets | 44.05%-299.44M | 4.51%-1.08B | -19.75%-535.2M | 47.18%-1.13B | 59.44%-446.93M | -44.52%-2.15B | -97.13%-1.1B | -136.01%-1.49B | -141.87%-558.93M | 25.73%-629.97M |
Selling intangible assets | ---- | ---- | ---- | ---- | ---- | --15.47M | ---- | ---- | ---- | ---- |
Purchase of intangible assets | 47.27%-819.43M | 38.65%-2.66B | 40.44%-1.55B | 32.71%-4.33B | 6.53%-2.61B | -14.28%-6.44B | -17.54%-2.79B | 6.34%-5.63B | 16.63%-2.37B | -40.75%-6.02B |
Sale of subsidiaries | ---- | ---- | ---- | 4,813.83%60.05M | ---- | -99.84%1.22M | ---- | --774.81M | ---- | ---- |
Acquisition of subsidiaries | ---- | 78.10%-86.04M | ---- | 78.83%-392.94M | ---- | -2,132.59%-1.86B | ---797.7M | 79.33%-83.13M | ---- | -17.60%-402.13M |
Recovery of cash from investments | --95.51M | --10.69M | ---- | ---- | ---- | --147.47M | --9.89M | ---- | ---- | ---- |
Cash on investment | -994.40%-13.48M | 69.12%-114.67M | 99.46%-1.23M | -3.30%-371.39M | 76.04%-229.62M | 77.75%-359.53M | -85.90%-958.17M | -70.46%-1.62B | 52.04%-515.42M | -338.74%-947.8M |
Other items in the investment business | -765.96%-9.34M | 836.62%2.84M | 90.68%-1.08M | -100.21%-385K | -106.45%-11.57M | 178.80%182.89M | 245.98%179.28M | -40.31%-232.09M | -2,708.42%-122.81M | -291.63%-165.42M |
Net cash from investment operations | 52.00%-1B | 37.43%-3.84B | 36.96%-2.09B | 41.14%-6.14B | 39.13%-3.32B | -26.42%-10.42B | -53.80%-5.45B | -49.40%-8.25B | -103.41%-3.55B | 26.38%-5.52B |
Net cash before financing | 151.12%1.15B | 36.79%-1.34B | 47.00%-2.26B | 82.26%-2.13B | 48.70%-4.26B | 27.05%-11.99B | 7.66%-8.29B | -26.33%-16.43B | -72.92%-8.98B | -9.64%-13.01B |
Cash flow from financing activities | ||||||||||
New borrowing | -16.51%13.13B | 5.22%30.57B | 17.24%15.73B | -13.38%29.05B | -22.14%13.42B | 0.78%33.54B | 25.78%17.23B | 46.15%33.28B | 53.76%13.7B | 67.42%22.77B |
Refund | -1.21%-21.74B | -16.19%-35.4B | -66.53%-21.48B | -74.98%-30.46B | -93.54%-12.9B | -6.31%-17.41B | -14.65%-6.66B | -88.75%-16.38B | -51.20%-5.81B | -32.40%-8.68B |
Issuance of bonds | 13.54%9.04B | 62.39%13.88B | 7.81%7.96B | 47.72%8.55B | 104.14%7.39B | --5.79B | --3.62B | ---- | ---- | ---- |
Interest paid - financing | 10.03%-1.63B | 0.11%-3.48B | -4.61%-1.81B | -14.38%-3.48B | -30.55%-1.73B | -35.25%-3.04B | -25.39%-1.33B | -24.67%-2.25B | -35.75%-1.06B | -31.79%-1.8B |
Dividends paid - financing | 90.89%-64.68M | 21.45%-1.69B | 36.92%-710.25M | 13.96%-2.15B | 5.56%-1.13B | -32.47%-2.5B | -27.61%-1.19B | -10.59%-1.89B | -10.54%-934.36M | -42.27%-1.7B |
Absorb investment income | 88.02%30.17M | -73.46%26.76M | -72.78%16.05M | -62.26%100.84M | -26.11%58.94M | -41.44%267.2M | -52.70%79.77M | -50.64%456.31M | -69.14%168.62M | 234.58%924.55M |
Issuance expenses and redemption of securities expenses | ---- | -156.14%-5.23B | ---- | -96.22%-2.04B | -3,719.72%-1.19B | -174.83%-1.04B | ---31.14M | ---378.89M | ---- | ---- |
Pledged bank deposit (increase) decrease | -88.98%93M | 245.41%956.34M | 1,925.61%843.63M | -311.60%-657.67M | -115.24%-46.21M | 218.11%310.8M | 165.60%303.15M | -147.76%-263.16M | -67.58%114.14M | 622.88%550.98M |
Other items of the financing business | -6.35%-189.3M | -2,327.70%-132.8M | -3,283.37%-178M | -116.98%-5.47M | -108.69%-5.26M | -100.10%-2.52M | -100.19%-2.52M | 221.60%2.44B | 6,939.81%1.36B | 2,464.09%759.94M |
Net cash from financing operations | -474.76%-1.34B | 52.21%-549.38M | -90.73%356.26M | -107.25%-1.15B | -67.96%3.84B | 5.93%15.85B | 59.54%11.99B | 17.17%14.97B | 46.71%7.52B | -18.40%12.77B |
Effect of rate | 47.26%-82.97M | 77.58%-264.55M | 71.91%-157.3M | -468.14%-1.18B | -339.36%-560.06M | -45.10%320.45M | 316.18%233.98M | 466.30%583.69M | -280.65%-108.23M | 48.51%-159.35M |
Net Cash | 90.40%-182.27M | 42.20%-1.89B | -360.32%-1.9B | -184.74%-3.28B | -111.15%-412.55M | 363.73%3.87B | 352.57%3.7B | -525.85%-1.47B | -1,984.79%-1.46B | -106.18%-234.21M |
Begining period cash | -20.38%8.43B | -29.61%10.59B | -29.61%10.59B | 38.54%15.05B | 38.54%15.05B | -7.51%10.86B | -7.51%10.86B | -3.24%11.74B | -3.24%11.74B | 40.19%12.14B |
Cash at the end | -4.30%8.17B | -20.38%8.43B | -39.36%8.53B | -29.61%10.59B | -4.87%14.07B | 38.54%15.05B | 45.47%14.79B | -7.51%10.86B | -15.52%10.17B | -3.24%11.74B |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.